Baillie Gifford & Co’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $43M | Sell |
492,854
-12,274
| -2% | -$1.07M | 0.03% | 157 |
|
2025
Q1 | $45.4M | Sell |
505,128
-12,252
| -2% | -$1.1M | 0.04% | 147 |
|
2024
Q4 | $41.3M | Sell |
517,380
-14,922
| -3% | -$1.19M | 0.03% | 152 |
|
2024
Q3 | $47.9M | Buy |
532,302
+99,747
| +23% | +$8.98M | 0.04% | 145 |
|
2024
Q2 | $34M | Sell |
432,555
-40,100
| -8% | -$3.16M | 0.03% | 157 |
|
2024
Q1 | $41.2M | Sell |
472,655
-6,089
| -1% | -$531K | 0.03% | 153 |
|
2023
Q4 | $39.4M | Buy |
478,744
+6,606
| +1% | +$544K | 0.03% | 165 |
|
2023
Q3 | $37M | Sell |
472,138
-6,307
| -1% | -$494K | 0.03% | 162 |
|
2023
Q2 | $42.2M | Buy |
478,445
+14,356
| +3% | +$1.26M | 0.04% | 161 |
|
2023
Q1 | $37.4M | Buy |
464,089
+28,444
| +7% | +$2.29M | 0.03% | 161 |
|
2022
Q4 | $33.9M | Buy |
435,645
+4,599
| +1% | +$357K | 0.04% | 164 |
|
2022
Q3 | $34.8M | Buy |
431,046
+9,901
| +2% | +$800K | 0.04% | 162 |
|
2022
Q2 | $37.8M | Buy |
421,145
+51,765
| +14% | +$4.65M | 0.04% | 166 |
|
2022
Q1 | $41M | Buy |
369,380
+22,292
| +6% | +$2.47M | 0.03% | 183 |
|
2021
Q4 | $35.9M | Buy |
347,088
+33,608
| +11% | +$3.48M | 0.02% | 201 |
|
2021
Q3 | $39.3M | Buy |
313,480
+7,914
| +3% | +$992K | 0.02% | 200 |
|
2021
Q2 | $37.9M | Buy |
305,566
+7,536
| +3% | +$935K | 0.02% | 204 |
|
2021
Q1 | $35.2M | Buy |
298,030
+89,283
| +43% | +$10.5M | 0.02% | 201 |
|
2020
Q4 | $24.5M | Sell |
208,747
-140
| -0.1% | -$16.4K | 0.01% | 191 |
|
2020
Q3 | $21.7M | Buy |
208,887
+3,334
| +2% | +$346K | 0.01% | 179 |
|
2020
Q2 | $18.8M | Buy |
+205,553
| New | +$18.8M | 0.01% | 172 |
|